2016 Novartis Medal and Prize awarded to David Tollervey

Tellervey_Novartis_prize.jpgDavid Tollervey was presented with the 2016 Novartis Medal and Prize by the Biochemical Society at the 81st Harden Conference: RNA and Disease in Winchester at the beginning of September.

He was awarded the medal and prize "in recognition of the influence he has had on the field of RNA Biology worldwide. Amongst David's many contributions, two themes are particularly noteworthy. Firstly, his work on the ribosome biogenesis which has been instrumental in identifying and characterising many of the factors involved in the synthesis, processing, assembly and maturation of the subunits which has led to a detailed understanding of the multiple-step pathways involved. Secondly, his ground-breaking work on RNA degradation complexes including the exosome."

The Novartis Medal and Prize is awarded annually in recognition of contributions to the development of any branch of biochemistry. Donated in 1964 by the Ciba Laboratories, Horsham (later Ciba-Geigy), the award is for work carried out in the UK or Republic of Ireland but is open to candidates of any nationality.

The recipient of the Prize receives the Novartis Medal and an honorarium of £3000. The award lecture is delivered at a Society conference, and the awardee is invited to submit an article to a Society-owned publication.

Further information about the Novartis Medal and Prize can be found on the Biochemical Society website at http://www.biochemistry.org/Awards/TheNovartisMedalandPrize.aspx